Build New Drugs "On Demand" With Bacteria, Cornell University Study

A new method of bacterial cell engineering promises better, cheaper drug therapies than those made from animal cells. Therapeutic proteins, which provide cutting-edge treatments for cancer, diabetes, and countless other diseases, are among today’s most widely consumed biopharmaceuticals. By introducing bottom-up carbohydrate engineering into common bacterial cells, Cornell University researchers have discovered a way to make these drugs cheaper and safer.

Back to news